首页> 外国专利> CD3-NEGATIVE CELL POPULATION EXPRESSING CHEMOKINE RECEPTOR AND CELL ADHESION MOLECULE, USE THEREOF, AND METHOD FOR PRODUCING SAME

CD3-NEGATIVE CELL POPULATION EXPRESSING CHEMOKINE RECEPTOR AND CELL ADHESION MOLECULE, USE THEREOF, AND METHOD FOR PRODUCING SAME

机译:表达趋化因子受体和细胞粘附分子的CD3阴性细胞群体,使用其的方法及其制备方法

摘要

The present invention pertains to immune cells having higher cytotoxic activity, and a pharmaceutical composition for performing highly effective NK cell therapy. The present invention provides a cell population containing cells that are CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative. The present invention provides a cell population in which cells that are CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative furthermore express a high level of CD11c. The present invention provides cells that invade solid tumors and are CCR5-positive, CCR6-positive, CXCR3-positive, and CD3-negative. The present invention also provides a pharmaceutical composition containing such a cell population and a pharmacologically acceptable additive. Furthermore, the present invention provides a method for producing the cell population.
机译:本发明涉及具有更高细胞毒性活性的免疫细胞,以及用于进行高效NK细胞疗法的药物组合物。本发明提供了含有CCR5阳性,CCR6阳性,CXCR3阳性和CD3阴性的细胞的细胞群。本发明提供了细胞群,其中CCR5阳性,CCR6阳性,CXCR3阳性和CD3阴性的细胞还表达高水平的CD11c。本发明提供侵袭实体瘤并且CCR5阳性,CCR6阳性,CXCR3阳性和CD3阴性的细胞。本发明还提供了含有这种细胞群和药理学上可接受的添加剂的药物组合物。此外,本发明提供了产生细胞群的方法。

著录项

  • 公开/公告号WO2019189115A1

    专利类型

  • 公开/公告日2019-10-03

    原文格式PDF

  • 申请/专利权人 GAIA BIOMEDICINE INC.;YONEMITSU YOSHIKAZU;

    申请/专利号WO2019JP12744

  • 发明设计人 HARADA YUI;

    申请日2019-03-26

  • 分类号C12N5/0783;A61K35/17;A61P35;

  • 国家 WO

  • 入库时间 2022-08-21 11:52:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号